SOLUBLE INTERLEUKIN-2 RECEPTOR IN PATIENTS WITH GLOMERULAR-DISEASES

Citation
Hs. Chen et al., SOLUBLE INTERLEUKIN-2 RECEPTOR IN PATIENTS WITH GLOMERULAR-DISEASES, Postgraduate medical journal, 71(840), 1995, pp. 617-622
Citations number
20
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00325473
Volume
71
Issue
840
Year of publication
1995
Pages
617 - 622
Database
ISI
SICI code
0032-5473(1995)71:840<617:SIRIPW>2.0.ZU;2-Q
Abstract
In this study, we measured the soluble interleukin-2 receptor (sIL-2R) level to evaluate the cellular immune status in 61 patients with diff erent types of glomerular diseases; 40 healthy volunteers were used as control. All patients with glomerular diseases had levels of serum sI L-2R significantly higher than those of the controls (766 +/- 59 vs 28 0 +/- 23 U/ml; p < 0.05). Even patients with normal renal function sti ll had higher serum sIL-2R levels than the controls, no matter to whic h subgroups they belonged (primary glomerulonephritis, lupus nephritis or diabetic nephropathy). Serum sIL-2R levels were similar among the three subgroups. The serum levels of sIL-2R correlated well with age a nd were significantly higher in older patients, although this was not observed in the control group. Serum sIL-2R levels were significantly higher in patients with active urinary sediment and in patients with i mpaired renal function and showed a significant negative correlation w ith creatinine clearance (r = -0.56; p < 0.05). Although urinary and s erum sIL-2R levels were quite well correlated, (r = 0.35; p < 0.05), t he urinary levels of sIL-2R did not differ in patients with different disease activity or different renal functions although they had a sign ificant correlation with 24-hour urinary protein (r = 0.39; p < 0.05). Patients with nephrotic syndrome also had higher urinary sIL-2R level s than other patients (529 +/- 106 vs 280 +/- 31 U/ml; p < 0.05). We c onclude that greater T-cell activation might contribute to the pathoge nesis of different glomerulonephritis entities, and serum levels of sI L-2R can serve as a useful clinical marker of glomerulonephritis activ ity. Renal function influenced the serum levels of sIL-2R significantl y. This factor must be considered when we interpret the data. Urinary sIL-2R levels did not reflect the disease activity as well. This might be due to the secondary influence of the extent of the glomerular pro tein leak. Further investigation is needed to define the exact excreto ry pathway of this substance.